2026-10-25
NewMarket clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,813 +0.55%
S&P 7,744 +0.28%
GOLD $4,071 −0.10%
BTC $79,851 −1.18%
VIX 16.91 −3.48%
latest tape · as of 02:01 UTC
The Screen · Basic Materials · Specialty Chemicals
NewMarket Corporation
NEU · the NYSE · USD · Market cap $8.1B · 2,050 employees
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives.
Not yet scored870.60 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price870.60 USD at the 23 Oct 2026 close
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.27)
- Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 870.60 against the desk's fair-value range, base estimate 435.30, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.27, read 2026-10-28
- Ethical screen not yet scored
Price870.60 USD
Fair value435.30
Ethical score70.0/100
Our investment reviews on this name
2026-10-21Read Markdown879.70-1.0% to today ✓Accumulation gives way to Markdown after a 5% slide in 6 weeks
2026-09-06Read Accumulation930.72-6.5% to today Markup gives way to Accumulation after a 7% rise in 4 weeks
2026-08-06Read Markup867.02+0.4% to today ✓Accumulation gives way to Markup with volume flow in agreement
2026-07-02Read Accumulation833.33+4.5% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
NewMarket Corporation holds its Markdown at $870.60. The statistical read favours the sellers, held for 40 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 40 days |
| Price at the screen | $870.60 |
| Valuation | 18.93 trailing · 34.07 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.56 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 27.97% | Below 33% | Interest-bearing debt is just 28.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 12.60% | Below 49% | Money owed to the company is 12.6% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
NewMarket clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
NewMarket clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 28%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 50.0% above the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAdditives Maker Commands Premium Despite Shrinking Sales
Picture every lorry and factory engine quietly relying on the right chemical mix to keep running. NewMarket supplies those petroleum additives, yet its shares sit at 770 dollars against a fair value near 385. Revenue is already sliding 4 percent and the forward multiple of 29.8 times earnings leaves no cushion for the swings that define specialty chemicals.
The business earns a solid 15 percent profit margin and 25 percent return on equity, and it clears the ethical screen. Those strengths, however, cannot offset the absence of any margin of safety. In a cyclical sector, high multiples often signal peak conditions rather than durable growth, which is why the opportunity rating stays at none.
Valuation risk is the core issue here. A sharp downturn in lubricant demand would compress earnings quickly, and the current price offers no protection against that outcome. Analysis, not advice.
| Forward P/E | 34.1xexpensive even after accounting for its growth |
| Trailing P/E | 18.9xreasonably valued |
| EPS, trailing | 46.47 |
| EPS, forward | 25.82 |
| Revenue growth | +7.0%slow but positive growth |
| Profit margin | 15.8%healthy profit margins |
| Return on equity | 25.1%an exceptional return on shareholder capital |
| FCF yield | 5.38% |
| Dividend yield | 141.00% |
| Debt to equity | 0.51moderate, manageable leverage |
| Current ratio | 2.25comfortably covers its short-term bills |
| Beta | 0.56steadier than the market |
| Short interest, float | 0.08% |
| 52-week range | 580.03 - 981.66 |
| Market cap | $8.1B |
| Employees | 2,050 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeNEU trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-28
Markdown $879.70
+0.0% Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Markdown $879.70
+0.0% Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Markdown $879.70
+0.0% Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Markdown $879.70
+0.0% Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Markdown $879.70
+0.0% Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Markdown $879.70
+0.0% Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Markdown $879.70
+0.0% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Markdown · changed $879.70
-1.5% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 16% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14
Accumulation $893.36
-3.0% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
2026-10-02
Accumulation $921.14
-1.0% Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- NewMarket (NEU) Stock May Offer A 35% Discount To Cash Flow Yahoo Finance · 5d ago
- NewMarket Corporation Schedules Conference Call and Webcast to Review Third Quarter 2026 Results Yahoo Finance · 23d ago
- NewMarket Corp's Dividend Analysis GuruFocus.com · 15 Sep 2026
- NewMarket Corp's Dividend Analysis Yahoo Finance · 15 Sep 2026
- NewMarket Corporation Announces Quarterly Dividend Yahoo Finance · 13 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
ESIElement Solutions Inc
WLKWestlake Corp
AXTAAxalta Coating Systems Ltd.
EMNEastman Chemical Company
SOLSSolstice Advanced Materials Inc
SSLSasol Limited
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $686.25 | +19.9% | · | $1,199 | +19.9% |
| 2 months | $628.74 | +30.9% | · | $1,309 | +30.9% |
| 3 months | $585.06 | +40.6% | $3.00 | $1,411 | +41.1% |
| 6 months | $766.78 | +7.3% | $6.00 | $1,081 | +8.1% |
| 1 year | $649.75 | +26.6% | $11.50 | $1,284 | +28.4% |
| 2 years | $513.07 | +60.4% | $21.75 | $1,646 | +64.6% |
| 3 years | $379.86 | +116.6% | $31.00 | $2,248 | +124.8% |
| 5 years | $302.46 | +172.0% | $47.60 | $2,877 | +187.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NEU does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.